#7 - Hims & Hers Health (NYSE:HIMS)
Hims & Hers Health (NYSE: HIMS) is one of the leading telehealth companies in the world. The company is expanding its portfolio to include a broader range of services, and investors are taking note. HIMS stock is up 64% in the last 12 months.
Revenue is growing strongly supported by the company's subscriber base, which increased 48% in 2023 to over 1.5 million members. The company is also forecasting strong revenue growth in 2024 in a range of $1.17 and $1.20 billion.
Perhaps more importantly, the company reported positive earnings in its most recent quarter. The company is projecting earnings growth to continue in the next 12 months, but analysts are bringing down their price targets. That sentiment appears to be changing. In late February, several analysts began raising their price targets for HIMS stock.
About Hims & Hers Health
Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Read More - Current Price
- $26.20
- Consensus Rating
- Hold
- Ratings Breakdown
- 8 Buy Ratings, 8 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $22.80 (13.0% Downside)
Stocks under $20 are appropriate for both traders and investors. In fact, many investors have stocks under $20 as part of a diversified portfolio. These stocks are frequently perceived as being more volatile than higher-priced blue-chip stocks.
However, frequently, the risk profile of these stocks has a tighter correlation to stocks with a higher price tag. And investors also speculate that these stocks could have market-beating upside while putting much less capital at risk.
However, as is the case with all stocks, you have to know where to look. To help you in your research, MarketBeat provides a free tool for investors. Under the Market Data tab, you'll find a section titled Low Priced Stocks. You can look at a list of stocks in specific categories (i.e., Stocks Under $5, Stocks Under $10, etc.) that is updated to include the stocks that receive Strong Buy or Buy ratings from Wall Street's top analysts.
More Investing Slideshows:
